Literature DB >> 31435878

Standardized versus research-based PAM50 intrinsic subtyping of breast cancer.

A Prat1,2,3, J S Parker4,5.   

Abstract

Entities:  

Year:  2019        PMID: 31435878     DOI: 10.1007/s12094-019-02203-x

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


× No keyword cloud information.
  17 in total

1.  Clinical implementation of the intrinsic subtypes of breast cancer.

Authors:  Charles M Perou; Joel S Parker; Aleix Prat; Matthew J Ellis; Philip S Bernard
Journal:  Lancet Oncol       Date:  2010-08       Impact factor: 41.316

2.  Everolimus plus Exemestane for Hormone Receptor-Positive Advanced Breast Cancer: A PAM50 Intrinsic Subtype Analysis of BOLERO-2.

Authors:  Aleix Prat; Jan Christoph Brase; Yuan Cheng; Paolo Nuciforo; Laia Paré; Tomás Pascual; Débora Martínez; Patricia Galván; Maria Vidal; Barbara Adamo; Gabriel N Hortobagyi; José Baselga; Eva Ciruelos
Journal:  Oncologist       Date:  2019-01-24

3.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.

Authors:  T Sørlie; C M Perou; R Tibshirani; T Aas; S Geisler; H Johnsen; T Hastie; M B Eisen; M van de Rijn; S S Jeffrey; T Thorsen; H Quist; J C Matese; P O Brown; D Botstein; P E Lønning; A L Børresen-Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-11       Impact factor: 11.205

4.  Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Authors:  Juan M Cejalvo; Eduardo Martínez de Dueñas; Patricia Galván; Susana García-Recio; Octavio Burgués Gasión; Laia Paré; Silvia Antolín; Rosella Martinello; Isabel Blancas; Barbara Adamo; Ángel Guerrero-Zotano; Montserrat Muñoz; Paolo Nucíforo; María Vidal; Ramón M Pérez; José I Chacón López-Muniz; Rosalía Caballero; Vicente Peg; Eva Carrasco; Federico Rojo; Charles M Perou; Javier Cortés; Vincenzo Adamo; Joan Albanell; Roger R Gomis; Ana Lluch; Aleix Prat
Journal:  Cancer Res       Date:  2017-03-01       Impact factor: 12.701

5.  A genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancer.

Authors:  Christos Hatzis; Lajos Pusztai; Vicente Valero; Daniel J Booser; Laura Esserman; Ana Lluch; Tatiana Vidaurre; Frankie Holmes; Eduardo Souchon; Hongkun Wang; Miguel Martin; José Cotrina; Henry Gomez; Rebekah Hubbard; J Ignacio Chacón; Jaime Ferrer-Lozano; Richard Dyer; Meredith Buxton; Yun Gong; Yun Wu; Nuhad Ibrahim; Eleni Andreopoulou; Naoto T Ueno; Kelly Hunt; Wei Yang; Arlene Nazario; Angela DeMichele; Joyce O'Shaughnessy; Gabriel N Hortobagyi; W Fraser Symmans
Journal:  JAMA       Date:  2011-05-11       Impact factor: 56.272

6.  Molecular portraits of human breast tumours.

Authors:  C M Perou; T Sørlie; M B Eisen; M van de Rijn; S S Jeffrey; C A Rees; J R Pollack; D T Ross; H Johnsen; L A Akslen; O Fluge; A Pergamenschikov; C Williams; S X Zhu; P E Lønning; A L Børresen-Dale; P O Brown; D Botstein
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

7.  Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer.

Authors:  Deena M A Gendoo; Natchar Ratanasirigulchai; Markus S Schröder; Laia Paré; Joel S Parker; Aleix Prat; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2015-11-24       Impact factor: 6.937

8.  Cyclin E1 Expression and Palbociclib Efficacy in Previously Treated Hormone Receptor-Positive Metastatic Breast Cancer.

Authors:  Nicholas C Turner; Yuan Liu; Zhou Zhu; Sherene Loi; Marco Colleoni; Sibylle Loibl; Angela DeMichele; Nadia Harbeck; Fabrice André; Mohamed Amine Bayar; Stefan Michiels; Zhe Zhang; Carla Giorgetti; Monica Arnedos; Cynthia Huang Bartlett; Massimo Cristofanilli
Journal:  J Clin Oncol       Date:  2019-02-26       Impact factor: 44.544

9.  PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

Authors:  Roy R L Bastien; Álvaro Rodríguez-Lescure; Mark T W Ebbert; Aleix Prat; Blanca Munárriz; Leslie Rowe; Patricia Miller; Manuel Ruiz-Borrego; Daniel Anderson; Bradley Lyons; Isabel Álvarez; Tracy Dowell; David Wall; Miguel Ángel Seguí; Lee Barley; Kenneth M Boucher; Emilio Alba; Lisa Pappas; Carole A Davis; Ignacio Aranda; Christiane Fauron; Inge J Stijleman; José Palacios; Antonio Antón; Eva Carrasco; Rosalía Caballero; Matthew J Ellis; Torsten O Nielsen; Charles M Perou; Mark Astill; Philip S Bernard; Miguel Martín
Journal:  BMC Med Genomics       Date:  2012-10-04       Impact factor: 3.063

10.  Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.

Authors:  Aleix Prat; Maggie C U Cheang; Patricia Galván; Paolo Nuciforo; Laia Paré; Barbara Adamo; Montserrat Muñoz; Margarida Viladot; Michael F Press; Robert Gagnon; Catherine Ellis; Stephen Johnston
Journal:  JAMA Oncol       Date:  2016-10-01       Impact factor: 33.006

View more
  5 in total

1.  Correlative Biomarker Analysis of Intrinsic Subtypes and Efficacy Across the MONALEESA Phase III Studies.

Authors:  Aleix Prat; Anwesha Chaudhury; Nadia Solovieff; Laia Paré; Débora Martinez; Nuria Chic; Olga Martínez-Sáez; Fara Brasó-Maristany; Agnes Lteif; Tetiana Taran; Naveen Babbar; Fei Su
Journal:  J Clin Oncol       Date:  2021-03-26       Impact factor: 44.544

2.  Identifying the link between chemical exposures and breast cancer in African American women via integrated in vitro and exposure biomarker data.

Authors:  Katelyn M Polemi; Vy K Nguyen; Julien Heidt; Adam Kahana; Olivier Jolliet; Justin A Colacino
Journal:  Toxicology       Date:  2021-09-30       Impact factor: 4.221

3.  Deconvolution of the Genomic and Epigenomic Interaction Landscape of Triple-Negative Breast Cancer.

Authors:  Jiande Wu; Tarun Karthik Kumar Mamidi; Lu Zhang; Chindo Hicks
Journal:  Cancers (Basel)       Date:  2019-10-31       Impact factor: 6.639

4.  A comparison of rule-based and centroid single-sample multiclass predictors for transcriptomic classification.

Authors:  Pontus Eriksson; Nour-Al-Dain Marzouka; Gottfrid Sjödahl; Carina Bernardo; Fredrik Liedberg; Mattias Höglund
Journal:  Bioinformatics       Date:  2021-11-12       Impact factor: 6.937

5.  RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer.

Authors:  Johan Staaf; Jari Häkkinen; Cecilia Hegardt; Lao H Saal; Siker Kimbung; Ingrid Hedenfalk; Tonje Lien; Therese Sørlie; Bjørn Naume; Hege Russnes; Rachel Marcone; Ayyakkannu Ayyanan; Cathrin Brisken; Rebecka R Malterling; Bengt Asking; Helena Olofsson; Henrik Lindman; Pär-Ola Bendahl; Anna Ehinger; Christer Larsson; Niklas Loman; Lisa Rydén; Martin Malmberg; Åke Borg; Johan Vallon-Christersson
Journal:  NPJ Breast Cancer       Date:  2022-08-16
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.